SHC Sotera Health Co - 8-K

Item 5.07. Submission of Matters to a Vote of Security Holders.

Sotera Health Company (the “Company”) held its 2026 annual meeting of stockholders on May 21, 2026 (the “Annual Meeting”). At the Annual Meeting, the stockholders (1) elected all four director nominees as Class III directors to serve a three-year term until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified, (2) approved, on an advisory basis, the compensation of the Company’s named executive officers, and (3) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

The final results on each of the matters submitted to a vote are as follows:

1. Election of Directors

Name

For

Withheld

Broker Non-Votes

Sean L. Cunningham

226,297,734

38,018,512

3,273,595

Richard G. Kyle

260,365,658

3,950,588

3,273,595

Vincent K. Petrella

251,933,894

12,382,352

3,273,595

Christopher A. Simon

253,840,543

10,475,703

3,273,595

2. Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers

For

Against

Abstain

Broker Non-Votes

257,678,396

6,586,053

51,797

3,273,595

3. Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm

For

Against

Abstain

Broker Non-Votes

267,310,915

223,069

55,857

N/A